Liyuan Li

1.6k total citations
52 papers, 1.2k citations indexed

About

Liyuan Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Liyuan Li has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Liyuan Li's work include Cancer, Hypoxia, and Metabolism (9 papers), Sirtuins and Resveratrol in Medicine (7 papers) and Cancer Cells and Metastasis (5 papers). Liyuan Li is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Sirtuins and Resveratrol in Medicine (7 papers) and Cancer Cells and Metastasis (5 papers). Liyuan Li collaborates with scholars based in China, United States and Japan. Liyuan Li's co-authors include Zhao Wang, Xiaojin Shi, Yun Shi, Yi Lu, Yi Lü, Ying Qiu, Zhuoran Wang, Zhongchi Li, Liqin Zhu and David Finkelstein and has published in prestigious journals such as Cell, PLoS ONE and Hepatology.

In The Last Decade

Liyuan Li

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liyuan Li China 18 629 218 172 146 140 52 1.2k
Jie Hao China 22 544 0.9× 85 0.4× 122 0.7× 143 1.0× 134 1.0× 58 1.2k
Yanni Xu China 18 650 1.0× 203 0.9× 146 0.8× 181 1.2× 110 0.8× 62 1.3k
Eduardo Cremonese Filippi‐Chiela Brazil 20 920 1.5× 172 0.8× 237 1.4× 225 1.5× 490 3.5× 59 1.8k
Jinshun Pan China 18 708 1.1× 355 1.6× 196 1.1× 444 3.0× 167 1.2× 30 1.4k
Christelle Laguillier France 17 377 0.6× 238 1.1× 251 1.5× 109 0.7× 271 1.9× 33 1.4k
Haiying Dong China 22 621 1.0× 202 0.9× 103 0.6× 292 2.0× 77 0.6× 46 1.3k
Han Liu China 18 463 0.7× 238 1.1× 57 0.3× 96 0.7× 71 0.5× 43 966

Countries citing papers authored by Liyuan Li

Since Specialization
Citations

This map shows the geographic impact of Liyuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyuan Li more than expected).

Fields of papers citing papers by Liyuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyuan Li. The network helps show where Liyuan Li may publish in the future.

Co-authorship network of co-authors of Liyuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Liyuan Li. A scholar is included among the top collaborators of Liyuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyuan Li. Liyuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Anthony, Qingfei Pan, Émilie Indersie, et al.. (2023). Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse. Communications Biology. 6(1). 249–249. 3 indexed citations
2.
Tian, Cheng, Liyuan Li, Qingfei Pan, et al.. (2023). Spatiotemporal regulation of cholangiocarcinoma growth and dissemination by peritumoral myofibroblasts in a Vcam1-dependent manner. Oncogene. 42(15). 1196–1208. 2 indexed citations
3.
Tian, Cheng, Liyuan Li, Li Fan, et al.. (2023). A hepatoprotective role of peritumoral non-parenchymal cells in early liver tumorigenesis. Disease Models & Mechanisms. 16(3). 4 indexed citations
4.
Li, Liyuan, Xinyu Guo, Yunpeng Liu, et al.. (2023). A multilayer perceptron-based model applied to histopathology image classification of lung adenocarcinoma subtypes. Frontiers in Oncology. 13. 1172234–1172234. 7 indexed citations
5.
Zeng, Chenye, Binliang Liu, Liyuan Li, et al.. (2023). Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling. Acta Pharmaceutica Sinica B. 13(6). 2680–2700. 25 indexed citations
6.
Pan, Qingfei, Wentao Yang, Selene C. Koo, et al.. (2022). A developmentally prometastatic niche to hepatoblastoma in neonatal liver mediated by the Cxcl1/Cxcr2 axis. Hepatology. 76(5). 1275–1290. 8 indexed citations
7.
Chen, Huiling, Xiaojin Shi, Liyuan Li, et al.. (2022). Astrocytic SIRT6 is a potential anti-depression and anti-anxiety target. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 123. 110702–110702. 8 indexed citations
8.
Li, Liyuan, et al.. (2022). Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19. Frontiers in Pharmacology. 13. 1013428–1013428. 11 indexed citations
9.
Li, Liyuan, et al.. (2020). Nonlinear Dynamics and Applications of Spin Hall Nano-Oscillators. Progress in physics. 40(6). 189. 1 indexed citations
10.
Li, Liyuan, et al.. (2020). Advances in immunoregulation effects of Ganoderma lucidum polysaccharide and/or Polyporus umbellatus polysaccharide.. Shipin Kexue / Food Science. 41(17). 275–282. 2 indexed citations
11.
Wang, Zhao, Wei Mu, Liyuan Li, Qingfei Liu, & Yong Ju. (2018). Metformin promotes the proliferation and differentiation of murine preosteoblast by regulating the expression of sirt6 and oct4. Proceedings for Annual Meeting of The Japanese Pharmacological Society. WCP2018(0). PO3–4. 2 indexed citations
12.
Li, Zhongchi, Kang Xu, Nannan Zhang, et al.. (2018). Overexpressed SIRT6 attenuates cisplatin-induced acute kidney injury by inhibiting ERK1/2 signaling. Kidney International. 93(4). 881–892. 88 indexed citations
13.
Mu, Wei, Zhuoran Wang, Zhuoran Wang, et al.. (2017). Metformin promotes the proliferation and differentiation of murine preosteoblast by regulating the expression of sirt6 and oct4. Pharmacological Research. 129. 462–474. 49 indexed citations
14.
Li, Liyuan, Maoxiang Qian, I‐Hsuan Chen, et al.. (2017). Acquisition of Cholangiocarcinoma Traits during Advanced Hepatocellular Carcinoma Development in Mice. American Journal Of Pathology. 188(3). 656–671. 26 indexed citations
15.
Li, Liyuan, Melissa Johnson, Christopher Calabrese, et al.. (2016). Abstract B38: Identification of highly metastatic disseminating tumor cells in late-stage liver cancer lung metastasis. Cancer Research. 76(7_Supplement). B38–B38. 15 indexed citations
16.
Madu, Chikezie O., Liyuan Li, & Yi Lü. (2016). Selection, Analysis and Improvement of Anti-Angiogenesis Compounds Identified by an Anti-HIF-1α Screening and Validation System. Journal of Cancer. 7(14). 1926–1938. 6 indexed citations
17.
Zhang, Jun, Liyuan Li, & Yi Lü. (2015). Effects of Hypoxia, Surrounding Fibroblasts, and p16 Expression on Breast Cancer Cell Migration and Invasion. Journal of Cancer. 6(5). 430–437. 6 indexed citations
18.
Li, Liyuan, et al.. (2011). Mechanism of increased respiration in an H+-ATPase-defective mutant of Corynebacterium glutamicum. Journal of Bioscience and Bioengineering. 113(4). 467–473. 16 indexed citations
19.
Li, Liyuan & Yi Lu. (2011). Optimizing a 3D Culture System to Study the Interaction between Epithelial Breast Cancer and Its Surrounding Fibroblasts. Journal of Cancer. 2. 458–466. 55 indexed citations
20.
Li, Liyuan & Yi Lü. (2010). Inhibition of Hypoxia-Induced Cell Motility by p16 in MDA-MB-231 Breast Cancer Cells. Journal of Cancer. 1. 126–135. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026